Marquee Middle Image

Faculty Profile

Vinayaka R. Prasad, Ph.D.

Dr. Vinayaka R. Prasad
 

Professional Interests

Research in our laboratory is focused on three areas of HIV/AIDS: replication mechanisms, therapeutics and pathogenesis.

HIV Replication Mechanisms: We have a long-standing interest in elucidating the mechanistic basis of key steps in HIV-1 replication. In earlier work, we delineated the determinants of fidelity of DNA synthesis by RT. We are currently focused on the interaction between the cellular factors and viral proteins that are crucial for HIV-1 replication.

RNA aptamers targeting HIV: For over a decade, we are developing and testing the efficacy of novel, anti-HIV-1 RNA aptamers to inhibit HIV-1 replication in cell culture. Aptamers are sequences isolated by the iterative process of SELEX and are highly specific to their targets. The most efficacious aptamers identified in our laboratory as well as combinations of them could be tested in nonhuman primates (macaques). We will introduce such aptamers into hematopoeitic stem cells, which will then be used in bone marrow transplantation followed by challenge with chimeric, pathogenic SHIVs. In earlier work, we have done considerable amount of work on anti-RT aptamers. We have now generated new aptamers to other viral targets including structural, catalytic and accessory proteins of HIV (Gag, Protease and Nef). Perturbation of HIV-1 Gag and viral RNA interaction using anti-Gag aptamers has provided new insights showing that preventing Gag-RNA binding causes down-modulation of viral RNA thus inhibiting virus production. We are currently characterizing the Nef aptamers to understand the specific Nef functions in HIV replication that are affected by each aptamer.

HIV associated Dementia: The severe form of HIV associated dementia (HAD) is common among clade-B HIV-infected individuals in the US, but less common among individuals infected with clade-C HIV-1 such as in India, suggesting that there are clade-specific differences in neuropathogenicity. Understanding clade-specific determinants of neuropathogenesis may shed light on the disease mechanism and help develop targeted drugs for HAD. We previously showed that clade C Tat lacks the chemokine function of Clade B Tat that plays a crucial role in the increased brain infiltration of monocytic phagocytes in HAD. We study neuropathogenesis induced by the two HIV-1 clades using SCID mouse HIV encephalitis (SCID-HIVE) model, where it has been shown that introduction of clade B HIV into SCID mouse brain recapitulates the key features of the human HAD disease. We found that, mice exposed to similar inputs of HIVIndie-C1 (clade C) made fewer memory errors than those exposed to HIV-1ADA (clade B). HIV-1ADA also caused greater astrogliosis and loss of neuronal network integrity.

Recent reports challenged the notion that clade C HIV-1 causes lower incidence of HAD by showing that South Africa and Botswana have a higher incidence of HAD (25-38%). Therefore, we examined whether Southern African HIV-1C is genetically distinct and investigated its neurovirulence. We focused our study on the variations seen in tat gene and its contribution to HIV associated neuropathogenesis. A phylogenetic analysis of tat sequences of Southern African HIV isolates with those from the geographically distant Southeast Asian (India and Bangladesh) isolates revealed that Southern African tat sequences are distinct from Southeast Asian isolates. The proportion of HIV − 1C variants with an intact dicysteine motif in Tat protein (C30C31) was significantly higher in the Southern African countries (20-25%) compared to Southeast Asia (2-3%) and broadly paralleled the incidence of HAD in these countries respectively. Neuropathogenic potential of a Southern African HIV-1C isolate (from Zambia; HIV-1C1084i), a HIV-1C isolate (HIV-1IndieC1) from Southeast Asia and a HIV-1B isolate (HIV-1ADA) from the US were tested using in vitro assays to measure neurovirulence and a SCID mouse HIV encephalitis model to measure cognitive deficits. In vitro assays revealed that the Southern African isolate, HIV-1C1084i exhibited increased monocyte chemotaxis and greater neurotoxicity compared to Southeast Asian HIV-1C. In neurocognitive tests, SCID mice injected with MDM infected with Southern African HIV-1C1084i showed greater cognitive dysfunction similar to HIV-1B but much higher than those exposed to Southeast Asian HIV − 1C.

Our results indicate that Tat dicysteine motif determines neurovirulence. If confirmed in population studies, it may be possible to predict neurocognitive outcomes of individuals infected with HIV-1C by genotyping Tat.

 

Selected Publications

HIV-1 Replication Mechanisms

  1. Lwatula, C., Garforth, SJ and Prasad, VR (2012) Lys66 as a determinant of high mismatch extension and misinsertion rates of HIV-1 reverse transcriptase FEBS J 2012 Aug 28. doi:10.1111/j.1742-4568.2012.08807.x.[Epub ahead of print]
  2. Garforth, S. J., Domaoal, R. A., Lwatula, C., Landau, M. J., Meyer, A. J., Anderson, K. S. and Vinayaka Prasad (2010) K65R and K65A substitutions in HIV-1 reverse transcriptase enhance polymerase fidelity by decreasing both dNTP misinsertion and mispaired primer extension efficiencies. J. Mol. Biol. 401:33-44.
  3. Garforth, S.,Parniak, M. A. and Prasad, V. R. (2008) Utilization of deoxynucleoside diphosphates as substrate by a DNA polymerase. Plos One. 3(4):e2074.
  4. Garforth, S., Lee, T. W., Parniak, M. A., Kool, E. T. and Prasad, V. R. (2007) Site-directed mutagenesis in the fingers subdomain of HIV-1 reverse transcriptase reveals a specific role for the b3-b4 hairpin loop in dNTP selection. J. Mol. Biol. 365:38-49
  5. Mandal, D., Dash, C. V., Le Grice, S. F. and Prasad V. R. (2006) Analysis of HIV-1 replication block due to substitutions at F61 residue of reverse transcriptase reveals additional defects involving RNase H function. Nuc. Acids Res. 34:2853-2863.

RNA aptamers targeted to HIV-1

  1. Ramalingam, D, Duclair, S., Datta, S., Ellington, A.D., Rein, A. and Prasad, V. R. (2010) RNA aptamers directed to HIV-1 Gag bind to the matrix and nucleocapsid domains and inhibit virus production. J. Virol. 85:305-314.
  2. Joshi. P., North, T. W. and Prasad, V. R. (2005) Aptamers Directed to HIV-1 Reverse Transcriptase Display Greater Efficacy over Small Hairpin RNAs Targeted to Viral RNA in Blocking HIV-1 Replication. Mol. Ther. 11:677-686.

HIV Neuropathogenesis

  1. Rao, V., Neogi, U., Talboom, J. S., Padilla, L., Rahman, M., Fritz-French, C, Gonzalez-Ramirez, Verma, A., Wood, C., Ruprecht, R. M., Ranga, U., Azim, T., Joska, John, Eugenin, T., Shet, A., Bimonte-Nelson, Tyor, W. R. and Prasad, V. R. (2013) Clade C HIV-1 isolates circulating in Southern Africa exhibit a greater frequency of dicysteine motif-containing Tat variants than those in Southeast Asia and cause increased neurovirulence. Retrovirology 10:61. DOI: 10.1186/1742-4690-10-61.
  2. Neogi, U., Gupta, S., Sahoo, PN, Shet, A., Ranga, U. and Prasad, VR (2012) Genetic characterization of HIV type 1 Tat Exon 1 from a South Indian clinical cohort: Identification of unique epidemiological signature residues. AIDS Res. Hum Retroviruses 28:952-956.
  3. Rao, V. R., Sas, A., Eugenin, E., Siddappa, N. B., Bimonte-Nelson, H., Berman, J., Ranga, U., Tyor, W. R. and Prasad, V. R. (2008) HIV-1 clade-specific differences in the induction of neuropathogenesis. J. Neurosci. 28:10010-6.
  4. Dash, P. K., Siddappa, N. B., Mangaiarkarasi, A., Anand, K. K., Padmanabhan, R. B, Mahendarkar, A. V., Mahadevan, A., Satishchandra, P., Shankar, S. K., Prasad, V. R., Ranga, U. (2008) Expanded coreceptor use of Human Immunodeficiency Virus Type-1 subtype C molecular isolates from an Indian subject with HIV-1 associated dementia. Retrovirology. 5:25
  5. Ranga, U., Shankarappa, R., Siddappa, N. B., Lakshmi, R., Nagendran, R., Mahalingam, M., Mahadevan, A., Jayasuryan, N., Satishchandra, P., Shankar, S.K. and Prasad, V. R. (2004)Tat protein of HIV-1subtype-C viruses is a defective chemokine. J. Virol. 78:2586-2590.

  

 

Material in this section is provided by individual faculty members who are solely responsible for its accuracy and content.

Contact

Albert Einstein College of Medicine
Jack and Pearl Resnick Campus
1300 Morris Park Avenue
Golding Building, Room 401
Bronx, NY 10461

Tel: 718.430.2517
vinayaka.prasad@einstein.yu.edu

 
Collexis Research Profiles
Einstein Research Profiles (ERP) is one of the innovative technologies to create collaborative bridges within and across the entire bench-to-bedside-to-population spectrum of research. The ERP website has been developed in partnership with Collexis to give investigators easy access to PubMed publications, coauthor networks, information about NIH grants, and research networks.